BlackRock, Inc. 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-09-09 3:52 pm Sale |
2020-08-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
BlackRock Inc. BLK |
79,095 4.700% |
-1,739 (-2.15%) |
Filing |